Literature DB >> 24451378

Histone deacetylase inhibitors modulate the transcriptional regulation of guanylyl cyclase/natriuretic peptide receptor-a gene: interactive roles of modified histones, histone acetyltransferase, p300, AND Sp1.

Prerna Kumar1, Satyabha Tripathi, Kailash N Pandey.   

Abstract

Atrial natriuretic peptide (ANP) binds guanylyl cyclase-A/natriuretic peptide receptor-A (GC-A/NPRA) and produces the intracellular second messenger, cGMP, which regulates cardiovascular homeostasis. We sought to determine the function of histone deacetylases (HDACs) in regulating Npr1 (coding for GC-A/NPRA) gene transcription, using primary mouse mesangial cells treated with class-specific HDAC inhibitors (HDACi). Trichostatin A, a pan inhibitor, and mocetinostat (MGCD0103), a class I HDAC inhibitor, significantly enhanced Npr1 promoter activity (by 8- and 10-fold, respectively), mRNA levels (4- and 5.3-fold, respectively), and NPRA protein (2.7- and 3.5-fold, respectively). However, MC1568 (class II HDAC inhibitor) had no discernible effect. Overexpression of HDAC1 and HDAC2 significantly attenuated Npr1 promoter activity, whereas HDAC3 and HDAC8 had no effect. HDACi-treated cultured cells in vitro and intact animals in vivo showed significantly reduced binding of HDAC1 and -2 and increased accumulation of acetylated H3-K9/14 and H4-K12 at the Npr1 promoter. Deletional analyses of the Npr1 promoter along with ectopic overexpression and inhibition of Sp1 confirmed that HDACi-induced Npr1 gene transcription is accomplished by Sp1 activation. Furthermore, HDACi attenuated the interaction of Sp1 with HDAC1/2 and promoted Sp1 association with p300 and p300/cAMP-binding protein-associated factor; it also promoted the recruitment of p300 and p300/cAMP-binding protein-associated factor to the Npr1 promoter. Our results demonstrate that trichostatin A and MGCD0103 enhanced Npr1 gene expression through inhibition of HDAC1/2 and increased both acetylation of histones (H3-K9/14, H4-K12) and Sp1 by p300, and their recruitment to Npr1 promoter. Our findings define a novel epigenetic regulatory mechanism that governs Npr1 gene transcription.

Entities:  

Keywords:  Chromatin Histone Modification; Gene Transcription; Histone Deacetylase Inhibitors; Natriuretic Peptides; Sp1; p300

Mesh:

Substances:

Year:  2014        PMID: 24451378      PMCID: PMC3945360          DOI: 10.1074/jbc.M113.511444

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  63 in total

1.  Characterization of a cGMP-response element in the guanylyl cyclase/natriuretic peptide receptor A gene promoter.

Authors:  David Hum; Sandrine Besnard; Rocio Sanchez; Dominic Devost; Francis Gossard; Pavel Hamet; Johanne Tremblay
Journal:  Hypertension       Date:  2004-04-19       Impact factor: 10.190

2.  Selective class I histone deacetylase inhibition suppresses hypoxia-induced cardiopulmonary remodeling through an antiproliferative mechanism.

Authors:  Maria A Cavasin; Kim Demos-Davies; Todd R Horn; Lori A Walker; Douglas D Lemon; Nicholas Birdsey; Mary C M Weiser-Evans; Julie Harral; David C Irwin; Adil Anwar; Michael E Yeager; Min Li; Peter A Watson; Raphael A Nemenoff; Peter M Buttrick; Kurt R Stenmark; Timothy A McKinsey
Journal:  Circ Res       Date:  2012-01-26       Impact factor: 17.367

3.  Green tea polyphenols causes cell cycle arrest and apoptosis in prostate cancer cells by suppressing class I histone deacetylases.

Authors:  Vijay S Thakur; Karishma Gupta; Sanjay Gupta
Journal:  Carcinogenesis       Date:  2011-11-23       Impact factor: 4.944

Review 4.  The family of guanylyl cyclase receptors and their ligands.

Authors:  J G Drewett; D L Garbers
Journal:  Endocr Rev       Date:  1994-04       Impact factor: 19.871

5.  A rapid and potent natriuretic response to intravenous injection of atrial myocardial extract in rats.

Authors:  A J de Bold; H B Borenstein; A T Veress; H Sonnenberg
Journal:  Life Sci       Date:  1981-01-05       Impact factor: 5.037

6.  Histone deacetylase (HDAC) inhibitor activation of p21WAF1 involves changes in promoter-associated proteins, including HDAC1.

Authors:  C-Y Gui; L Ngo; W S Xu; V M Richon; P A Marks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-01-20       Impact factor: 11.205

7.  Molecular evolution of the histone deacetylase family: functional implications of phylogenetic analysis.

Authors:  Ivan V Gregoretti; Yun-Mi Lee; Holly V Goodson
Journal:  J Mol Biol       Date:  2004-04-16       Impact factor: 5.469

8.  Atrial natriuretic factor: a hormone produced by the heart.

Authors:  A J de Bold
Journal:  Science       Date:  1985-11-15       Impact factor: 47.728

9.  Molecular cloning and expression of murine guanylate cyclase/atrial natriuretic factor receptor cDNA.

Authors:  K N Pandey; S Singh
Journal:  J Biol Chem       Date:  1990-07-25       Impact factor: 5.157

Review 10.  Cardiac histone acetylation--therapeutic opportunities abound.

Authors:  Timothy A McKinsey; Eric N Olson
Journal:  Trends Genet       Date:  2004-04       Impact factor: 11.639

View more
  18 in total

1.  Histone deacetylase 10 suppresses proliferation and invasion by inhibiting the phosphorylation of β-catenin and serves as an independent prognostic factor for human clear cell renal cell carcinoma.

Authors:  Wenxing Fan; Jie Huang; Hua Xiao
Journal:  Int J Clin Exp Med       Date:  2015-03-15

2.  Decreased expression of histone deacetylase 10 predicts poor prognosis of gastric cancer patients.

Authors:  Ziliang Jin; Weihua Jiang; Feng Jiao; Zhen Guo; Hai Hu; Lei Wang; Liwei Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-08-15

3.  Histone deacetylation contributes to low extracellular superoxide dismutase expression in human idiopathic pulmonary arterial hypertension.

Authors:  Eva Nozik-Grayck; Crystal Woods; Robert S Stearman; Sujatha Venkataraman; Bradley S Ferguson; Kalin Swain; Russell P Bowler; Mark W Geraci; Kaori Ihida-Stansbury; Kurt R Stenmark; Timothy A McKinsey; Frederick E Domann
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2016-05-27       Impact factor: 5.464

4.  Retinoic acid and sodium butyrate suppress the cardiac expression of hypertrophic markers and proinflammatory mediators in Npr1 gene-disrupted haplotype mice.

Authors:  Umadevi Subramanian; Prerna Kumar; Indra Mani; David Chen; Isaac Kessler; Ramu Periyasamy; Giri Raghavaraju; Kailash N Pandey
Journal:  Physiol Genomics       Date:  2016-05-06       Impact factor: 3.107

5.  Atrial natriuretic peptide down-regulates LPS/ATP-mediated IL-1β release by inhibiting NF-kB, NLRP3 inflammasome and caspase-1 activation in THP-1 cells.

Authors:  Letizia Mezzasoma; Cinzia Antognelli; Vincenzo Nicola Talesa
Journal:  Immunol Res       Date:  2016-02       Impact factor: 2.829

6.  Transforming growth factor β1 antagonizes the transcription, expression and vascular signaling of guanylyl cyclase/natriuretic peptide receptor A - role of δEF1.

Authors:  Anagha Sen; Prerna Kumar; Renu Garg; Sarah H Lindsey; Prasad V G Katakam; Meaghan Bloodworth; Kailash N Pandey
Journal:  FEBS J       Date:  2016-04-05       Impact factor: 5.542

Review 7.  Histone Deacetylases Inhibitors in the Treatment of Retinal Degenerative Diseases: Overview and Perspectives.

Authors:  Hua Zhang; Xufeng Dai; Yan Qi; Ying He; Wei Du; Ji-Jing Pang
Journal:  J Ophthalmol       Date:  2015-06-02       Impact factor: 1.909

8.  HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.

Authors:  Filippo Turrini; Sara Marelli; Anna Kajaste-Rudnitski; Marina Lusic; Carine Van Lint; Atze T Das; Alex Harwig; Ben Berkhout; Elisa Vicenzi
Journal:  Retrovirology       Date:  2015-12-18       Impact factor: 4.602

Review 9.  Guanylyl cyclase/natriuretic peptide receptor-A signaling antagonizes phosphoinositide hydrolysis, Ca(2+) release, and activation of protein kinase C.

Authors:  Kailash N Pandey
Journal:  Front Mol Neurosci       Date:  2014-08-22       Impact factor: 5.639

10.  HDAC-inhibition counteracts everolimus resistance in renal cell carcinoma in vitro by diminishing cdk2 and cyclin A.

Authors:  Eva Juengel; Snigdha Nowaz; Jasmina Makarevi; Iyad Natsheh; Isabella Werner; Karen Nelson; Michael Reiter; Igor Tsaur; Jens Mani; Sebastian Harder; Georg Bartsch; Axel Haferkamp; Roman A Blaheta
Journal:  Mol Cancer       Date:  2014-06-16       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.